These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 19076563)

  • 1. Discrimination against children with severe allergies.
    Warner JO
    Pediatr Allergy Immunol; 2008 Dec; 19(8):671-2. PubMed ID: 19076563
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-IgE for asthma in inner-city children.
    Geraci C; Longo G
    N Engl J Med; 2011 Jun; 364(26):2557; author reply 2557-8. PubMed ID: 21714663
    [No Abstract]   [Full Text] [Related]  

  • 3. Omalizumab for childhood asthma.
    Warner JO
    Expert Rev Respir Med; 2010 Feb; 4(1):5-7. PubMed ID: 20387287
    [No Abstract]   [Full Text] [Related]  

  • 4. NICE guidance on omalizumab for severe asthma.
    Diaz RA; Charles Z; George E; Adler AI
    Lancet Respir Med; 2013 May; 1(3):189-90. PubMed ID: 24429120
    [No Abstract]   [Full Text] [Related]  

  • 5. [Omalizumab in severe asthma--case report].
    Gawlewicz-Mroczka A; Nizankowska-Mogilnicka E
    Pol Arch Med Wewn; 2006 Aug; 116(2):766-70. PubMed ID: 17424922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Summaries for patients. Omalizumab therapy for patients with severe asthma.
    Ann Intern Med; 2011 May; 154(9):I28. PubMed ID: 21536934
    [No Abstract]   [Full Text] [Related]  

  • 7. Omalizumab in asthma: is the therapeutic window too small?
    Bhat KD; Calhoun WJ
    Chest; 2011 Jan; 139(1):8-10. PubMed ID: 21208873
    [No Abstract]   [Full Text] [Related]  

  • 8. World Asthma and COPD Forum. Clinical trial results with omalizumab.
    D'Amato G
    IDrugs; 2008 Jul; 11(7):489-92. PubMed ID: 18600594
    [No Abstract]   [Full Text] [Related]  

  • 9. Omalizumab has a place in therapy for asthma disease management.
    Pesko LJ
    J Manag Care Pharm; 2009 Apr; 15(3):284-8. PubMed ID: 19326960
    [No Abstract]   [Full Text] [Related]  

  • 10. Anti-IgE for asthma in inner-city children.
    Pavord ID; Bush A
    N Engl J Med; 2011 Jun; 364(26):2556-7; author reply 2557-8. PubMed ID: 21714664
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of omalizumab treatment in a baker with occupational asthma.
    Pérez Pimiento A; Bueso Fernández A; García Loria J; Rodríguez Cabreros MI; Mosquera MR; García Cubero A
    J Investig Allergol Clin Immunol; 2008; 18(6):490-1. PubMed ID: 19123449
    [No Abstract]   [Full Text] [Related]  

  • 12. [Omalizumab, recombinant humanized monoclonal antibody anti-IgE -- new fields of studies on the therapeutic indications].
    Kupryś-Lipińska I; Kuna P
    Pneumonol Alergol Pol; 2009; 77(1):43-51. PubMed ID: 19308909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omalizumab treatment in a child with severe asthma and multiple steroid-induced morbidities.
    Rizk C; Ring A; Santucci S; MacLusky I; Karsh J; Yang WH
    Ann Allergy Asthma Immunol; 2012 Sep; 109(3):222-3. PubMed ID: 22920081
    [No Abstract]   [Full Text] [Related]  

  • 14. Does anti-IgE therapy help in asthma? Efficacy and controversies.
    Avila PC
    Annu Rev Med; 2007; 58():185-203. PubMed ID: 17059361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omalizumab for the treatment of exacerbations in children with inadequately controlled allergic (IgE-mediated) asthma.
    Lanier B; Bridges T; Kulus M; Taylor AF; Berhane I; Vidaurre CF
    J Allergy Clin Immunol; 2009 Dec; 124(6):1210-6. PubMed ID: 19910033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of a recombinant anti-immunoglobulin E antibody (omalizumab) in severe allergic asthma.
    Holgate ST; Chuchalin AG; Hébert J; Lötvall J; Persson GB; Chung KF; Bousquet J; Kerstjens HA; Fox H; Thirlwell J; Cioppa GD;
    Clin Exp Allergy; 2004 Apr; 34(4):632-8. PubMed ID: 15080818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pneumology. Anti-IgE antibodies in the treatment of asthma].
    Leuenberger P; Sauty A; Rochat T
    Rev Med Suisse; 2007 Jan; 3(93):56-9. PubMed ID: 17354662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Omralizumab (Xolair) in severe persistent allergic asthma].
    Schleich F; Manise M; Louis R
    Rev Med Liege; 2009; 64(5-6):313-7. PubMed ID: 19642466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eosinophilic pneumonia in an asthmatic patient treated with omalizumab therapy: forme-fruste of Churg-Strauss syndrome?
    Cazzola M; Mura M; Segreti A; Mattei MA; Rogliani P
    Allergy; 2009 Sep; 64(9):1389-90. PubMed ID: 19392997
    [No Abstract]   [Full Text] [Related]  

  • 20. The use of monoclonal antibodies and related agents in the treatment of respiratory disease.
    Schachter EN; Neuman T
    Drugs Today (Barc); 2009 Jul; 45(7):533-48. PubMed ID: 19834630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.